Skip to main content
. 2010 Jun 7;25(11):3707–3717. doi: 10.1093/ndt/gfq292

Table 5.

Actual bicarbonate, base excess, LDL-cholesterol and potassium at baseline, changes from baseline and at Week 25 (FAS, N = 244)

Parameter CaMg
Sevelamer-HCl
P-value
N (Mean ± SD) N (Mean ± SD)
Actual bicarbonate (mmol/L)
  Baseline 106 21.086 ± 2.6587 102 21.588 ± 3.4209
  Week 25 117 22.496 ± 3.3095 114 21.086 ± 4.0833
  Change at Week 25 106 1.500 ± 3.1117 101 −0.823 ± 4.3323 <0.0001
  Treatment difference (LS-means) [confidence interval] 1.8435 [0.9462, 2.7408] <0.0001
Base excess
  Baseline 110 −3.729 ± 2.9518 107 −3.133 ± 3.6341
  Week 25 121 −2.340 ± 3.4567 118 −3.702 ± 4.2831
  Change at Week 25 110 1.594 ± 3.2531 106 −0.853 ± 4.3851 <0.0001
  Treatment difference (LS-means) [confidence interval] 1.9466 [1.0171, 2.8761] <0.0001
LDL-cholesterol (mg/dL)
  Baseline 122 112.71 ± 31.717 122 115.03 ± 30.346
  Week 25 116 110.19 ± 30.060 105 87.17 ± 27.870
  Change at Week 25 116 −2.85 ± 21.458 105 −28.09 ± 25.746
  Treatment difference (LS-means) [confidence interval] 23.5287 [17.9405, 29.1169] <0.0001
Potassium (mmol/L)
  Baseline 122 5.50 ± 0.967 122 5.36 ± 0.732
  Week 25 118 5.79 ± 0.793 112 5.39 ± 0.807
  Change at Week 25 118 0.27 ± 0.968 112 0.03 ± 0.776
  Treatment difference (LS-means) [confidence interval] 0.3192 [0.1250, 0.5134] 0.0014